1. Signaling Pathways
  2. Metabolic Enzyme/Protease
    PI3K/Akt/mTOR
  3. IPK Superfamily

IPK Superfamily 

Inositiol Polyphosphate Kinase (IPK) Superfamily

Inositiol Polyphosphate Kinase (IPK) Superfamily is a family of enzymes that have a similar 3-dimensional structure. All members of the family catalyze the transfer of phosphate groups from ATP to various inositol phosphates. Members of the family include inositol-polyphosphate multikinases (IPMK), inositol-hexakisphosphate kinases, inositol-trisphosphate 3-kinases (PI3K) and inositol-pentakisphosphate 2-kinase (IP5P2K). Members of the IPK superfamily play important roles in various signaling pathways by altering the phosphorylation state of the second messenger inositol phosphates. Some members of the IPK superfamily are involved in regulating inositol phosphate metabolism related to vesicle transport, ensuring the accurate progress of intracellular substance transport. Abnormal functions of IPK superfamily members are closely related to the occurrence and development of various diseases, such as cancer, neurological diseases, and metabolic diseases[1][2][3].

IPK Superfamily 相关产品 (9):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-150607
    UNC7467 Inhibitor 98.07%
    UNC7467 是一种有效的 IP6K抑制剂,IP6K2、IP6K1 和 IP6K6 的 IC50 值分别为 4.9、8.9 和1320 nM。UNC7467 可降低肌醇焦磷酸盐的水平。UNC7467 可用于肥胖研究。
    UNC7467
  • HY-110079
    TNP Inhibitor 99.29%
    TNP是 IP6K1IP3K 的抑制剂, 其对IP6K1 和IP3K 的IC50 值分别为 0.55 µM 和 10.2 μM。TNP 与两个酶的ATP结合位点结合。
    TNP
  • HY-153530
    LI-2242 Inhibitor 98.95%
    LI-2242 是一种肌醇六磷酸激酶 (IP6K) 抑制剂。 LI-2242 对 IP6K1、IP6K2、IP6K3 和 IPMK 具有抑制作用,IC50 值分别为 31 nM、42 nM、8.7 nM 和 1944 nM。LI-2242 可用于 II 型糖尿病、肥胖、代谢并发症、静脉血栓和精神疾病的研究。
    LI-2242
  • HY-P4195A
    [K15,R16,L27]VIP(1-7)/GRF(8-27) acetate Agonist
    [K15,R16,L27]VIP(1-7)/GRF(8-27) (acetate) 是 [K15,R16,L27]VIP(1-7)/GRF(8-27) (HY-P4195) 的醋酸盐形式。[K15,R16,L27]VIP(1-7)/GRF(8-27) (acetate) 是 VIP1 的激动剂对人肠血管活性肽 1 (VIP 1), 大鼠肠血管活性肽 1 (VIP 1) 和大鼠肠血管活性肽 2 (VIP 2) 结合 IC50 值分别为? 2 nM,1 nM 和 30000 nM。
    [K15,R16,L27]VIP(1-7)/GRF(8-27) acetate
  • HY-P4195
    [K15,R16,L27]VIP(1-7)/GRF(8-27) Agonist
    [K15,R16,L27]VIP(1-7)/GRF(8-27) 是 VIP1 的激动剂对人肠血管活性肽 1 (VIP 1), 大鼠肠血管活性肽 1 (VIP 1) 和大鼠肠血管活性肽 2 (VIP 2) 结合 IC50 值分别为 2 nM,1 nM 和 30000 nM。
    [K15,R16,L27]VIP(1-7)/GRF(8-27)
  • HY-122706A
    IP6K2-IN-2 Inhibitor 98.85%
    IP6K2-IN-2 (Compound 6) 是一种 IP6K2 抑制剂,针对 IP6K2IP6K1IP6K3IC50 值分别为 0.58 μM、0.86 μM 和 3.08 μM。IP6K2-IN-2 可用于肥胖症研究。
    IP6K2-IN-2
  • HY-162821
    LI-3948 Inhibitor
    IP6K-IN-2 (compound 29c) 是一种具有口服生物活性和血脑屏障透过性的 IP6K 抑制剂 (IC50: 15.8 nM),能够用于中枢神经系统疾病的研究。
    LI-3948
  • HY-162016
    IP6K-IN-1 Inhibitor
    IP6K-IN-1 (compound 24) 是一种有效的 IP6K 选择性抑制剂,其 IC50 为 0.896 μM。IP6K-IN-1 可用于代谢性疾病的研究。
    IP6K-IN-1
  • HY-161032
    IP6K2-IN-1 Inhibitor
    IP6K2-IN-1 (Compd 20s) 是选择性的 IP6K2 抑制剂,其 ICIC50 值为 0.55 μM。
    IP6K2-IN-1